SEPN Competitors & Alternatives
Compare Septerna, Inc. Common Stock with similar stocks in the same industry
Biotechnology
SEPN
Main Stock$37.71
Tradestie Score
49
Market Cap
$847.12M
Revenue Growth
223.8%
Analyst Upside
+43.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CELC
Celcuity Inc. Common Stock
|
$72.10
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.64
|
$1.90B | 21.5 | 42 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.42
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.71
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.74
|
$1.78B | - | 37 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.20
|
$1.78B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.67
|
$1.77B | - | 32 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.40
|
$1.74B | - | 51 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.65
|
$1.68B | - | 60 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 50 | Compare |
More SEPN Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry